No abstract available
Keywords:
CRISPR-Cas9; gene therapy; hypoxia; neuroprotection; retinal metabolism.
Grants and funding
Support for this study came from grants from the Tubitak (118C226 and 121N275), Sabanci University Integration Grant (EPD-2020-14), Sabanci University Presidential Research Funds (H-2021-0356), and Tuseb (16719) to CA and Research Council Kantonsspital Aarau (1410.000.188) to MT and CA.